Researchers studied the relationship between the distribution of centers that perform percutaneous microaxial VAD implantation and cardiogenic shock outcomes.

The right therapy can dramatically boost the self-healing capabilities of the human heart after heart failure, a new study ...

Cardiologists at UC Davis Health are among the first in the country to use a novel, low-profile device to improve blood flow ...

It may open the door to new ways to treat and perhaps someday cure heart failure, the deadliest non-communicable disease on ...

The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...

With dropping temperatures in many parts of the country, the general public is reminded of the accompanying risk of heart ...

Following allocation system changes in 2018, heart transplant waitlist mortality decreased in patients with LVADs.

An Austin man unknowingly became a huge milestone in the story, receiving Mayo Clinic’s 1,000th heart transplant.

Cadrenal Therapeutics (CVKD) recapped its 2024 milestones and highlighted a clear path forward to develop the investigational drug tecarfarin ...